Enterprise League logo
Vast Therapeutics Logo

Vast Therapeutics

Durham, United States (US) · Health and Medical

Do you work at Vast Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#pharmaceuticals

#biotech

#therapeutics

Vast Therapeutics is a Durham, North Carolina-based airway immunology company pioneering a novel approach to treating chronic respiratory diseases.We are dedicated to developing breakthrough medicines, leveraging our proprietary nitric oxide technology, to address the root causes of debilitating conditions like cystic fibrosis, bronchiectasis, and NTM lung disease.

Overview

Vast Therapeutics is a Durham, North Carolina-based airway immunology company pioneering a novel approach to treating chronic respiratory diseases.

We are dedicated to developing breakthrough medicines, leveraging our proprietary nitric oxide technology, to address the root causes of debilitating conditions like cystic fibrosis, bronchiectasis, and NTM lung disease. Our technology, based on stable prodrugs of nitric oxide, offers a unique ‘antimicrobial alternative’ resistant to common antibiotic resistance mechanisms.

Founded in 2017 and currently employing 11 people, Vast Therapeutics is committed to improving the lives of patients suffering from chronic lung disease. We are focused on advancing our pipeline through preclinical and clinical development, with a strong scientific advisory board and a dedicated team of experts.

Our team combines decades of experience in pharmaceutical development, respiratory medicine, and drug delivery, driving innovation and translating scientific breakthroughs into impactful therapies.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@vasttherapeutics.com

Durham, United States (US), 4222 Emporer Blvd. Suite 470

Founded

2017

Company Type

Private Limited Company

Employees

10-20

Categories

Biopharma
Life Science
Biotechnology

Keywords

#pharmaceuticals

#biotech

#therapeutics

Awards

• 2026 OpenSee all

Services

Default Product Image
Inhaled Therapy ALX1
Biotechnology

A novel inhaled therapy utilizing our proprietary nitric oxide technology for the treatment of chronic respiratory diseases, currently in Phase 1 clinical trials.

N/A

Companies teams usually look at after Vast Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.